News VALO HEALTHValo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular PlatformApril 05, 2022 TERRAN BIOSCIENCESTerran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platformMarch 16, 2022 PROJENXProJenX launches to advance novel, targeted therapies for ALS and other brain diseasesFebruary 16, 2022 BLACKROCK NEUROTECHHigh Performing Algorithm to Translate Paralyzed Patients' Thoughts into Real-time Prosthetic MovementsFebruary 08, 2022 TECH TRANSFER TACTICSColumbia program takes in non-university ventures to boost impact, grow ecosystemJanuary 27, 2022 EDIFECSEdifecs Enters Into Definitive Agreement to Acquire Health FidelityNovember 22, 2021 COLUMBIA NEWSColumbia Launches Startup Fellows Program to Extend Research Assets to EntrepreneursNovember 15, 2021 BRIDGEBIOBridgeBio Pharma Announces Collaborations with Columbia University and Mount Sinai to Develop Potential Therapies for Genetic Diseases and CancersOctober 29, 2021 SIVERS SEMICONDUCTORSSivers Semiconductors to acquire MixComm, a US mmWave challengerOctober 14, 2021 ENDPOINTSSalvaging 'ugly fruit': After a series of protein degradation bets, Versant turns to protein stabilization platform out of ColumbiaJune 03, 2021 Salvaging 'ugly fruit': After a series of protein degradation bets, Versant turns to protein stabilization platform out of ColumbiaJune 03, 2021 FORKHEADForkhead BioTherapeutics Awarded NIH SBIR Phase II GrantJune 01, 2021 Pagination « First First page ‹ Previous Previous page … 2 3 4 5 6 7 8 9 10 Next › Next page Last » Last page